295 related articles for article (PubMed ID: 16949678)
1. Age-associated changes within CD4+ T cells.
Kovaiou RD; Grubeck-Loebenstein B
Immunol Lett; 2006 Sep; 107(1):8-14. PubMed ID: 16949678
[TBL] [Abstract][Full Text] [Related]
2. Age-related changes in immunity: implications for vaccination in the elderly.
Kovaiou RD; Herndler-Brandstetter D; Grubeck-Loebenstein B
Expert Rev Mol Med; 2007 Feb; 9(3):1-17. PubMed ID: 17266794
[TBL] [Abstract][Full Text] [Related]
3. Reference values for CD4+ and CD8+ T lymphocytes with naïve or memory phenotype and their association with mortality in the elderly.
Provinciali M; Moresi R; Donnini A; Lisa RM
Gerontology; 2009; 55(3):314-21. PubMed ID: 19190395
[TBL] [Abstract][Full Text] [Related]
4. Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly.
Weinberger B; Lazuardi L; Weiskirchner I; Keller M; Neuner C; Fischer KH; Neuman B; Würzner R; Grubeck-Loebenstein B
Hum Immunol; 2007 Feb; 68(2):86-90. PubMed ID: 17321897
[TBL] [Abstract][Full Text] [Related]
5. Age-related susceptibility of naive and memory CD4 T cells to apoptosis induced by IL-2 deprivation or PHA addition.
Donnini A; Re F; Bollettini M; Moresi R; Tesei S; Bernardini G; Provinciali M
Biogerontology; 2005; 6(3):193-204. PubMed ID: 16041623
[TBL] [Abstract][Full Text] [Related]
6. Fading immune protection in old age: vaccination in the elderly.
Grubeck-Loebenstein B
J Comp Pathol; 2010 Jan; 142 Suppl 1():S116-9. PubMed ID: 19959180
[TBL] [Abstract][Full Text] [Related]
7. The aging of the immune system.
Weiskopf D; Weinberger B; Grubeck-Loebenstein B
Transpl Int; 2009 Nov; 22(11):1041-50. PubMed ID: 19624493
[TBL] [Abstract][Full Text] [Related]
8. CD4 memory T cells on trial: immunological memory without a memory T cell.
Bell EB; Westermann J
Trends Immunol; 2008 Sep; 29(9):405-11. PubMed ID: 18674966
[TBL] [Abstract][Full Text] [Related]
9. [Infections in the elderly. Part I. Etiology and pathogenesis].
Praczko K; Kostka T
Wiad Lek; 2006; 59(7-8):538-41. PubMed ID: 17209355
[TBL] [Abstract][Full Text] [Related]
10. Induction of alphadelta- and alphabeta-mediated T cell responses in healthy elderly subjects after influenza vaccination.
Re F; Donnini A; Provinciali M
Biogerontology; 2006 Aug; 7(4):249-59. PubMed ID: 16821115
[TBL] [Abstract][Full Text] [Related]
11. Th1 memory: implications for vaccine development.
Foulds KE; Wu CY; Seder RA
Immunol Rev; 2006 Jun; 211():58-66. PubMed ID: 16824117
[TBL] [Abstract][Full Text] [Related]
12. Biology of immune responses to vaccines in elderly persons.
Weinberger B; Herndler-Brandstetter D; Schwanninger A; Weiskopf D; Grubeck-Loebenstein B
Clin Infect Dis; 2008 Apr; 46(7):1078-84. PubMed ID: 18444828
[TBL] [Abstract][Full Text] [Related]
13. [Immunosenescence and the lung].
Duchateau J
Rev Mal Respir; 2003 Nov; 20(5 Pt 1):735-41. PubMed ID: 14631253
[TBL] [Abstract][Full Text] [Related]
14. [Immunogerontology--aging of the immune system and its cause].
Ptak W; Szczepanik M
Przegl Lek; 1998; 55(7-8):397-9. PubMed ID: 10021884
[TBL] [Abstract][Full Text] [Related]
15. Antigen-independent generation of a unique CD4 T cell-subset with aging and its persistent unresponsiveness.
Nishida E; Nishioka T; Iida R; Yagita H; Morita A; Shimizu J
Immunol Lett; 2008 Nov; 121(1):27-32. PubMed ID: 18718488
[TBL] [Abstract][Full Text] [Related]
16. Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
Fujihashi K; Kiyono H
Trends Immunol; 2009 Jul; 30(7):334-43. PubMed ID: 19540811
[TBL] [Abstract][Full Text] [Related]
17. When T cells get old.
Pawelec G
Sci Aging Knowledge Environ; 2005 Dec; 2005(50):pe39. PubMed ID: 16354906
[TBL] [Abstract][Full Text] [Related]
18. Multiple roles for CD4+ T cells in anti-tumor immune responses.
Kennedy R; Celis E
Immunol Rev; 2008 Apr; 222():129-44. PubMed ID: 18363998
[TBL] [Abstract][Full Text] [Related]
19. Impact of donor and recipient age on allograft tolerance.
Martins PN
Exp Clin Transplant; 2009 Jun; 7(2):67-77. PubMed ID: 19715510
[TBL] [Abstract][Full Text] [Related]
20. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
